Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market buy Director bought 20,000 shares at $57.03 ($1,140,600)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 4 Open-market buy Director bought 989,812 shares at $52.03 ($51,499,918)
  6. 8-K Event Other events
  7. 3/A Insider 3/A
  8. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 6 of 45 · 883 filings